Suleyman Demirel University
Isparta, 32100, Turkey (Türkiye)
Location status: Recruiting
Location contact
Pinar Yasar, MsC
CONTACT
NCT Number: NCT06705283
This study aimed to compare the effects of yoga and Whole Body Vibration Training on pelvic floor muscle strength, severity of urinary symptoms and UI-related quality of life in women with UI.
The intervention period for the study was determined as 6 weeks. It has been decided that yoga practice will be done 3 times a week for 45 minutes, and whole body vibration training will be done for 45-55 minutes. The home exercise group will perform the planned exercise protocol every day for 6 weeks.
The results of the study will be evaluated by statistical analysis as a result of the interventions and evaluations.
Interested in participating?
Request Info20 year–60 year
Female
Interventional
Not applicable
Isparta, 32100, Turkey (Türkiye)
Location status: Recruiting
Pinar Yasar, MsC
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention period for the study was determined as 6 weeks. It has been decided that yoga practice will be done 3 times a week for 45 minutes.
Poses to be practiced in the yoga group:
A total of 40-45 minutes of training was planned for WBVT, including warm-up (10 minutes), active phase (25-30 minutes) and cooling phase (5 minutes).
Pelvic floor muscle training will be done in the home exercise group. This training will be done in the form of slow and fast contractions of the pelvic floor muscles in supine, chin up, sitting, squat and standing positions.
Time frame: 6 weeks
Pelvic floor muscle strength evaluation will be performed with a perineal EMG biofeedback device with a vaginal probe. After the pressure probe is inserted into the vagina, the patient will be asked to contract the pelvic floor muscles. Contractions will be repeated 3 times and averaged. The obtained value will be recorded in cmH2O.
Time frame: 6 weeks
It is used for severity of urinary incontinence. The participant was asked "How much urine do you think you leak?" The question will be asked and the student will be asked to make a mark on the chart that scores between 0-10 points.0 means no urine leakage, 10 means a lot of urine leakage.
Time frame: 6 weeks
The scale addresses the frequency of UI and how much UI affects a person's life. There are a total of 4 questions, 3 of which are included in the scoring. A total of 0-21 points are given (0: no leakage, 1-5: mild, 6-12: moderate, 13-18: severe, 21: serious urine leakage). As the score increases, the severity of UI and the impact on quality of life increase.
Time frame: 6 weeks
30 min: walking and climbing stairs 45th minute: Coughing 10 times, sitting down and standing up 10 times, picking up something from the ground 10 times, jumping 10 times, washing hands under running water for 1 minute, running for 1 minute.
60th minute: Weighing the pad taken from the patient again. After the evaluation steps are completed, the amount of urine leakage is calculated by subtracting the weight of the clean pad from the weight of the used pad.
Time frame: 6 weeks
There are 7 items in the scale. Items are scored between 0-3, resulting in a total score between 0-21. It is understood that as the score obtained from the scale increases, the severity of UI complaints and quality of life decrease.
Time frame: 6 weeks
It consists of 6 questions. In the scoring of the scale, there are options for each item: 0: not at all, 1: slightly, 2: moderately, 3: very much. Minimum 0 - maximum 18 points can be obtained from UDI-6. The score is determined by converting the points received into a percentage. An increase in the score obtained from the scale indicates that the level of quality of life is deteriorating.
Contact information is provided by the study sponsor or research team.
Suleyman Demirel University
Other
Effects Of Yoga And Whole Body Vibration Training On Women With Stress Urinary Incontinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06094543
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Redwood City, California, United States
View Trial DetailsNCT05719220
BPH, Female Urogenital Diseases
San Francisco, California, United States
View Trial DetailsNCT07555548
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Doncaster, United Kingdom
View Trial DetailsNCT07524439
Dermatitis, Dermatitis, Contact
Edmonton, Alberta, Canada
View Trial Details